Production operations at the facility, which are focused on active pharmaceutical ingredients (APIs), were deemed to meet good manufacturing practice (GMP) standard following an inspection by the Medicines and Healthcare Products Regulatory Agency's (MHRA).
IPCA told the Hindu Business line that the Indore site, which is in one of the contry’s special economic zones (SEZ), “It is the fourth manufacturing unit of the company to have received such approval from UK MHRA.”